Suchergebnisse - "Migliori, Giovanni Battista"

PubPharm (76)

1

War in Ukraine : an immense threat to the fight against tuberculosis

enthalten in: The European respiratory journal | 2022

von Dahl, V. | Migliori, G. | Lange, C. | +1

CommentOn: Eur Respir J. 2021 Nov 11;58(5):. - PMID 34446465

2

Post-tuberculosis sequelae and their socioeconomic consequences : worth investigating

enthalten in: The Lancet. Global health | 2021

von Sotgiu, G. | Centis, R. | Migliori, G.

CommentOn: Lancet Glob Health. 2021 Dec;9(12):e1679-e1687. - PMID 34798027

3

Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia. Authors' reply

enthalten in: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia | 2021

von Zampogna, E. | Ambrosino, N. | Migliori, G. | +1

CommentOn: J Bras Pneumol. 2021 Sep 06;47(4):e20210277. - PMID 34495182

4

Intermittent regimens for tuberculosis treatment : Back to the Future?

enthalten in: The European respiratory journal | 2020

von Alffenaar, J. | Tiberi, S. | Cirillo, D. | +1

CommentOn: Eur Respir J. 2020 Sep 3;56(3):. - PMID 32430417

5

On tuberculosis and COVID-19 co-infection

enthalten in: The European respiratory journal | 2020

von Tadolini, M. | García-García, J. | Blanc, F. | +8

CommentOn: Eur Respir J. 2020 Jul 9;56(1):. - PMID 32457198

6

Tuberculosis in the time of COVID-19 : quality of life and digital innovation

enthalten in: The European respiratory journal | 2020

von Visca, D. | Tiberi, S. | Pontali, E. | +2

CommentOn: Eur Respir J. 2020 Aug 6;56(2):. - PMID 32366485

7

What is the best regimen to treat latent tuberculosis infection?

enthalten in: The Lancet. Infectious diseases | 2020

von Tiberi, S. | Migliori, G.

CommentOn: Lancet Infect Dis. 2020 Mar;20(3):318-329. - PMID 31866327

8

Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae

enthalten in: The European respiratory journal | 2019

von Visca, D. | Zampogna, E. | Sotgiu, G. | +8

CommentOn: Eur Respir J. 2018 Dec 6;52(6):. - PMID 30309977

9

Recent evidence on delamanid use for rifampicin-resistant tuberculosis

enthalten in: Journal of thoracic disease | 2019

von Pontali, E. | Centis, R. | D'Ambrosio, L. | +2

CommentOn: Eur Respir J. 2018 Jun 14;51(6):. - PMID 29724920

10

Delamanid : does it have a role in tuberculosis treatment?

enthalten in: The Lancet. Respiratory medicine | 2019

von Centis, R. | Sotgiu, G. | Migliori, G.

CommentOn: Lancet Respir Med. 2019 Mar;7(3):249-259. - PMID 30630778

1
2
3
4
5
6
7
8
Nächster »
[8]